Developer docs
API playgroundTry for free, no card

Search company profiles

Sealive

Full company profile

uuid000o9l9

Namestring
Sealive
Legal namestring
Sealive, Inc. (株式会社シーライブ)
Websiteurl
sealive.co.jp
Company typeenum
Private
Founded yearint
1995
Descriptiontext

Sealive, Inc. (株式会社シーライブ), founded in February 1995 in Niihama, Ehime Prefecture, Japan, was a privately held hardware and firmware engineering firm that operated two distinct business divisions from a single headquarters. The System Engineering Business delivered consignment-based design of high-reliability electronics for space and industrial customers, including onboard circuit design, FPGA SpaceWire logic (compliant with ECSS-E-ST-50-12C), DC-DC/DC-AC converters, and a proprietary MCP high-voltage 4-output power supply (5 kV DC, 200 kHz switching) used in JAXA/ISAS observation satellites such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H. Customers on this side included Sumitomo Heavy Industries, Symax, SEIKEN and PHC Corporation. The Life Science Business was built around Biovector®, a proprietary complex gas that the company describes as the only technology in the world that decomposes nucleic-acid (DNA/RNA) structures in the gas phase. Biovector® underpins the steriXcure GE100S Decontamination Gas Generator and the newly introduced compact steriXmini system, plus the setriX nucleic-acid decontamination service line, sold to pharmaceutical, laboratory, animal-research and regenerative-medicine customers with a Sterility Assurance Level of Log10⁻⁶ and 99.994% / LRV4.20 reduction of SARS-CoV-2.

The company monetized through a mix of one-time hardware sales, project-based decontamination installation services, and contract system-engineering engagements; pricing is quote-based with no public list, and customers are routed through bilingual Japanese/English inquiry forms on the corporate website. Go-to-market relied on direct enterprise sales supported by a heavy trade-show cadence (co-exhibiting with parent Mito Kogyo at Regenerative Medicine EXPO, PharmaLab EXPO, JALAS, JAET and Medical Creation Fukushima), Nature Index earned media, downloadable technical PDFs, and standard digital marketing infrastructure (Google Analytics, Mailchimp/AWeber/GetResponse). The technology base has been validated externally via AMED funding (2021) for novel-coronavirus countermeasure R&D, ISO 9001-based QMS, Ehime Sugo-waza and Niihama Manufacturing Brand certifications, and the 2022 Shikoku Industrial Technology Award for steriXcure.

As of October 1, 2025, Sealive was merged into Mito Kogyo Corporation (水戸工業株式会社) and continues to operate as the newly established Ehime Electrical and Electronic Design Center of Mito Kogyo, with founder-CEO Yasushi Suzuki serving as Center Director and Ryuzo Narita as Representative Director of the surviving parent.

Short descriptiontext

Sealive is a Japan-based hardware and firmware engineering firm that develops nucleic-acid-degrading gas-phase sterilization systems (steriXcure, steriXmini, Biovector®) and space-grade electronic design services for JAXA satellite missions, serving pharmaceutical, laboratory and aerospace customers from Niihama, Ehime.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNiihama, Japan
HQ citystring
Niihama
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gas-phase sterilization systems, DNA-free decontamination equipment, space-grade electronic design, bio-decontamination services, satellite onboard electronics
Industry4 codes
PRIMARYHLAGAGAC
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAACAN
Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
NAICS code3 codes
  • Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing333413
  • Aerospace Product and Parts Manufacturing3364
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Printed Circuit Boards3672
Product category
Gas-Phase Sterilization and Decontamination Equipment
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1steriXcure / steriXmini equipment sales
TypeHardware Sales
Description

One-time hardware sales of gas-phase decontamination systems (GE100S, steriXmini) to laboratory, pharmaceutical, animal-facility and medical-device customers.

sealive.co.jp
2Decontamination installation / nucleic-acid decontamination services
TypeProfessional Services
Description

Professional services offering site decontamination of nucleic-acid contaminated areas, preventive decontamination, and consultation services using the setriX series, charged per project/contract.

sealive.co.jp
3System Engineering contract design & development
TypeProfessional Services
Description

Consignment/contract-based revenue from system construction, hardware, firmware, and software design — including space-grade onboard electronics — delivered to enterprise customers.

sealive.co.jp
4HACCP management system marketing support (AWS-based)
TypeManaged Services
Description

Marketing support services for HACCP management systems based on AWS for life-science / food-safety customers.

sealive.co.jp
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Pricing details1 tier
1Quote-based pricing for steriXcure / steriXmini systems and decontamination services
ModelOtherBilling cadenceMulti-year contract
Notes

No public price list; customers must contact via the Life Science or System Engineering inquiry forms to receive an estimate.

sealive.co.jp
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1steriXcure
Description

Trademarked nucleic acid degradable gas-phase sterilization/decontamination product line for pathogens and viruses; the company's flagship life science brand encompassing the GE100S decontamination gas generator and the steriXmini compact DNA-free decontamination system.

sealive.co.jp
Core offering1 text field

Sealive designs, manufactures and sells gas-phase nucleic-acid decontamination systems (steriXcure GE100S and steriXmini) powered by its proprietary Biovector® complex gas, which decomposes DNA and RNA structures to deliver SAL = Log10⁻⁶ sterility and 99.994% / LRV4.20 reduction of SARS-CoV-2 in laboratory, pharmaceutical, clean-room and animal-facility environments. Alongside this Life Science line, the company delivers contracted space-grade hardware, firmware and PCB design services — including DC-DC converters, SpaceWire FPGA logic and 5 kV DC MCP high-voltage power supplies — for JAXA/ISAS scientific-satellite programs such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H/NeXT.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 99.994% virus reduction / LRV4.20 against SARS-CoV-2 (TCID50)
+4 more records
Product overview1 text field

Sealive (株式会社シーライブ), now operating as the Ehime Electrical and Electronic Design Center of Mito Kogyo Co., Ltd. (水戸工業株式会社) following an October 1, 2025 corporate merger, runs two distinct business divisions from its base in Niihama, Ehime Prefecture. The Life Science Business is built around the proprietary Biovector® nucleic-acid-degrading gas-phase technology and is commercialized primarily through the flagship steriXcure GE100S Decontamination Gas Generator, the newly introduced next-generation steriXmini DNA-free Decontamination System, and the setriX Series Nucleic Acid Decontamination Service — together forming an integrated hardware-plus-service offering for sterilization, DNA-free environment regeneration, viral clearance, and oxidative deodorization. The System Engineering Business complements this by providing space-grade hardware design, embedded software/firmware development, and printed circuit board design services, with a proven track record on JAXA/ISAS observation satellites. The two divisions are housed within the same electronics-engineering organization and share underlying competencies in electronic circuit design and embedded control, while targeting fundamentally different end markets (life-science laboratories and cleanrooms vs. space and industrial electronics).

Product and service1 record
1steriXcure GE100S Decontamination Gas Generator
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagship / CoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

As of October 1, 2025, Mito Kogyo Co., Ltd. merged with Sealive, Inc., and Sealive was newly established as the "Ehime Electrical and Electronic Design Center" of Mito Kogyo. All business operations and responsibilities of the former Sealive were fully succeeded by Mito Kogyo. Mito Kogyo Representative Director: Ryuzo Narita; Ehime Center Director: Yasushi Suzuki.

Strategic tierStrategic TierTypeGTM or Marketing Partner
Description

Featured in Nature Index — Infectious disease special, October 28, 2021, with the article "The next milestone in sterilization" highlighting steriXcure / Biovector. Provides international scientific credibility and earned-media visibility for the technology.

Strategic tierFlagship / CoreTypeChannel Partner/ Reseller/ Distributor
Description

Sealive exhibits inside the Mito Kogyo booth at major Japanese trade shows (PharmaLab EXPO Osaka booth 11-33; Regenerative Medicine EXPO Tokyo West Hall W7-26; JALAS booth F-9; JAET booth D-12; Medical Creation Fukushima booth A-1 within MECT booth), leveraging Mito Kogyo's larger commercial footprint.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Broad sterilization and infection-control equipment incumbent with a global service network serving hospitals, pharmaceutical manufacturers, and research labs. Overlaps with Sealive's life-science sterilization customer base as part of a much wider portfolio.

TypeEmerging player
Description

Nitrogen dioxide-based sterilization technology targeted at pharma, biotech, and medical-device customers. Comparable niche modality player focused on alternative gas-phase sterilization approaches for the same regulated buyers.

TypeDirect peer
Description

Hydrogen peroxide vapor decontamination systems for life-science and pharmaceutical cleanrooms, now part of Ecolab. Closely comparable technology approach and customer base to Sealive's gas-phase nucleic-acid decontamination.

TypeDirect peer
Description

Provider of SteraMist ionized hydrogen peroxide decontamination technology for life sciences, healthcare, and public-sector buyers. Comparable niche-scale player offering a differentiated gas-phase decontamination modality.

5NEC (NEC Space Technologies)
TypeBroad incumbent
Description

Long-standing Japanese supplier of space-grade electronic systems for JAXA and commercial satellite programs. Comparable in the System Engineering Business dimension as a large incumbent in satellite onboard electronics.

6STERIS
TypeDirect peer
Description

Global leader in sterilization and decontamination equipment for pharmaceutical, biotech, and medical-device customers. Directly comparable as a vendor of gas-/vapor-phase decontamination systems targeting the same regulated end markets Sealive serves with steriXcure.

TypeBroad incumbent
Description

Sterilization and disinfection solutions provider within J&J MedTech, serving hospitals and life-science customers. Broad incumbent overlapping with Sealive's decontamination end markets.

TypeBroad incumbent
Description

Major Japanese aerospace electronics manufacturer supplying satellite onboard systems. Comparable in the System Engineering Business dimension as a much larger incumbent in space-grade electronics design and manufacture.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sealive

Gas-Phase Sterilization and Decontamination Equipmentsealive.co.jp

Sealive is a Japan-based hardware and firmware engineering firm that develops nucleic-acid-degrading gas-phase sterilization systems (steriXcure, steriXmini, Biovector®) and space-grade electronic design services for JAXA satellite missions, serving pharmaceutical, laboratory and aerospace customers from Niihama, Ehime.

What Sealive does

Sealive, Inc. (株式会社シーライブ), founded in February 1995 in Niihama, Ehime Prefecture, Japan, was a privately held hardware and firmware engineering firm that operated two distinct business divisions from a single headquarters. The System Engineering Business delivered consignment-based design of high-reliability electronics for space and industrial customers, including onboard circuit design, FPGA SpaceWire logic (compliant with ECSS-E-ST-50-12C), DC-DC/DC-AC converters, and a proprietary MCP high-voltage 4-output power supply (5 kV DC, 200 kHz switching) used in JAXA/ISAS observation satellites such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H. Customers on this side included Sumitomo Heavy Industries, Symax, SEIKEN and PHC Corporation. The Life Science Business was built around Biovector®, a proprietary complex gas that the company describes as the only technology in the world that decomposes nucleic-acid (DNA/RNA) structures in the gas phase. Biovector® underpins the steriXcure GE100S Decontamination Gas Generator and the newly introduced compact steriXmini system, plus the setriX nucleic-acid decontamination service line, sold to pharmaceutical, laboratory, animal-research and regenerative-medicine customers with a Sterility Assurance Level of Log10⁻⁶ and 99.994% / LRV4.20 reduction of SARS-CoV-2.

The company monetized through a mix of one-time hardware sales, project-based decontamination installation services, and contract system-engineering engagements; pricing is quote-based with no public list, and customers are routed through bilingual Japanese/English inquiry forms on the corporate website. Go-to-market relied on direct enterprise sales supported by a heavy trade-show cadence (co-exhibiting with parent Mito Kogyo at Regenerative Medicine EXPO, PharmaLab EXPO, JALAS, JAET and Medical Creation Fukushima), Nature Index earned media, downloadable technical PDFs, and standard digital marketing infrastructure (Google Analytics, Mailchimp/AWeber/GetResponse). The technology base has been validated externally via AMED funding (2021) for novel-coronavirus countermeasure R&D, ISO 9001-based QMS, Ehime Sugo-waza and Niihama Manufacturing Brand certifications, and the 2022 Shikoku Industrial Technology Award for steriXcure.

As of October 1, 2025, Sealive was merged into Mito Kogyo Corporation (水戸工業株式会社) and continues to operate as the newly established Ehime Electrical and Electronic Design Center of Mito Kogyo, with founder-CEO Yasushi Suzuki serving as Center Director and Ryuzo Narita as Representative Director of the surviving parent.

Sealive firmographics

Firmographics
Name
Sealive
Legal name
Sealive, Inc. (株式会社シーライブ)
Website
https://sealive.co.jp
Company type
Private
Founded year
1995
Operating status
Acquired
Headcount range
11–50 employees
Short description
Sealive is a Japan-based hardware and firmware engineering firm that develops nucleic-acid-degrading gas-phase sterilization systems (steriXcure, steriXmini, Biovector®) and space-grade electronic design services for JAXA satellite missions, serving pharmaceutical, laboratory and aerospace customers from Niihama, Ehime.
Ownership category
akta.pro rank

Sealive industry classification

Industry
Product category
Gas-Phase Sterilization and Decontamination Equipment
NAICS
Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413), Aerospace Product and Parts Manufacturing (3364), Computer Systems Design and Related Services (54151)
SIC
Laboratory Analytical Instruments (3826), Printed Circuit Boards (3672)
akta.pro industry
PRIMARYHLAGAGAC
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGABAF
mRNA/LNP & Nucleic Acid Therapeutics CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAACAN
Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAAJAC
Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)

Keywords

  • Gas-phase sterilization systems
  • DNA-free decontamination equipment
  • Space-grade electronic design
  • Bio-decontamination services
  • Satellite onboard electronics

Where Sealive is headquartered

Location

Headquarters

HQ city
Niihama
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

Sealive business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. steriXcure / steriXmini equipment sales: One-time hardware sales of gas-phase decontamination systems (GE100S, steriXmini) to laboratory, pharmaceutical, animal-facility and medical-device customers.
  2. Decontamination installation / nucleic-acid decontamination services: Professional services offering site decontamination of nucleic-acid contaminated areas, preventive decontamination, and consultation services using the setriX series, charged per project/contract.
  3. System Engineering contract design & development: Consignment/contract-based revenue from system construction, hardware, firmware, and software design — including space-grade onboard electronics — delivered to enterprise customers.
  4. HACCP management system marketing support (AWS-based): Marketing support services for HACCP management systems based on AWS for life-science / food-safety customers.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for steriXcure / steriXmini systems and decontamination services

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Sealive product offering

Product offering

Core offering

Sealive designs, manufactures and sells gas-phase nucleic-acid decontamination systems (steriXcure GE100S and steriXmini) powered by its proprietary Biovector® complex gas, which decomposes DNA and RNA structures to deliver SAL = Log10⁻⁶ sterility and 99.994% / LRV4.20 reduction of SARS-CoV-2 in laboratory, pharmaceutical, clean-room and animal-facility environments. Alongside this Life Science line, the company delivers contracted space-grade hardware, firmware and PCB design services — including DC-DC converters, SpaceWire FPGA logic and 5 kV DC MCP high-voltage power supplies — for JAXA/ISAS scientific-satellite programs such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H/NeXT.

Product overview

Sealive (株式会社シーライブ), now operating as the Ehime Electrical and Electronic Design Center of Mito Kogyo Co., Ltd. (水戸工業株式会社) following an October 1, 2025 corporate merger, runs two distinct business divisions from its base in Niihama, Ehime Prefecture. The Life Science Business is built around the proprietary Biovector® nucleic-acid-degrading gas-phase technology and is commercialized primarily through the flagship steriXcure GE100S Decontamination Gas Generator, the newly introduced next-generation steriXmini DNA-free Decontamination System, and the setriX Series Nucleic Acid Decontamination Service — together forming an integrated hardware-plus-service offering for sterilization, DNA-free environment regeneration, viral clearance, and oxidative deodorization. The System Engineering Business complements this by providing space-grade hardware design, embedded software/firmware development, and printed circuit board design services, with a proven track record on JAXA/ISAS observation satellites. The two divisions are housed within the same electronics-engineering organization and share underlying competencies in electronic circuit design and embedded control, while targeting fundamentally different end markets (life-science laboratories and cleanrooms vs. space and industrial electronics).

Differentiator

Problem solved

Functional benefit

Brands

  • steriXcure: Trademarked nucleic acid degradable gas-phase sterilization/decontamination product line for pathogens and viruses; the company's flagship life science brand encompassing the GE100S decontamination gas generator and the steriXmini compact DNA-free decontamination system.

Products and services

  • steriXcure GE100S Decontamination Gas Generator

Quantifiable outcome

  • 99.994% virus reduction / LRV4.20 against SARS-CoV-2 (TCID50)
  • +4 more outcomes

Companies that use Sealive

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Sealive technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Sealive partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship / core and strategic tier.

  • Mito Kogyo Co., Ltd. (水戸工業株式会社)flagship / coreStrategic or Co-development Partner · 1 October 2025As of October 1, 2025, Mito Kogyo Co., Ltd. merged with Sealive, Inc., and Sealive was newly established as the "Ehime Electrical and Electronic Design Center" of Mito Kogyo. All business operations and responsibilities of the former Sealive were fully succeeded by Mito Kogyo. Mito Kogyo Representative Director: Ryuzo Narita; Ehime Center Director: Yasushi Suzuki.
  • Nature Research Custom Media (Nature Index)strategic tierGTM or Marketing PartnerFeatured in Nature Index — Infectious disease special, October 28, 2021, with the article "The next milestone in sterilization" highlighting steriXcure / Biovector. Provides international scientific credibility and earned-media visibility for the technology.
  • Mito Kogyo Co., Ltd. (booth partnership at trade shows)flagship / coreChannel Partner/ Reseller/ DistributorSealive exhibits inside the Mito Kogyo booth at major Japanese trade shows (PharmaLab EXPO Osaka booth 11-33; Regenerative Medicine EXPO Tokyo West Hall W7-26; JALAS booth F-9; JAET booth D-12; Medical Creation Fukushima booth A-1 within MECT booth), leveraging Mito Kogyo's larger commercial footprint.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Sealive competitors and assessment

Company assessment

Broad incumbents

  • Getinge: Broad sterilization and infection-control equipment incumbent with a global service network serving hospitals, pharmaceutical manufacturers, and research labs. Overlaps with Sealive's life-science sterilization customer base as part of a much wider portfolio.
  • NEC (NEC Space Technologies): Long-standing Japanese supplier of space-grade electronic systems for JAXA and commercial satellite programs. Comparable in the System Engineering Business dimension as a large incumbent in satellite onboard electronics.
  • Advanced Sterilization Products (Johnson & Johnson MedTech): Sterilization and disinfection solutions provider within J&J MedTech, serving hospitals and life-science customers. Broad incumbent overlapping with Sealive's decontamination end markets.
  • Mitsubishi Electric: Major Japanese aerospace electronics manufacturer supplying satellite onboard systems. Comparable in the System Engineering Business dimension as a much larger incumbent in space-grade electronics design and manufacture.

Emerging players

  • Noxilizer: Nitrogen dioxide-based sterilization technology targeted at pharma, biotech, and medical-device customers. Comparable niche modality player focused on alternative gas-phase sterilization approaches for the same regulated buyers.

Direct peers

  • Bioquell (Ecolab): Hydrogen peroxide vapor decontamination systems for life-science and pharmaceutical cleanrooms, now part of Ecolab. Closely comparable technology approach and customer base to Sealive's gas-phase nucleic-acid decontamination.
  • TOMI Environmental Solutions: Provider of SteraMist ionized hydrogen peroxide decontamination technology for life sciences, healthcare, and public-sector buyers. Comparable niche-scale player offering a differentiated gas-phase decontamination modality.
  • STERIS: Global leader in sterilization and decontamination equipment for pharmaceutical, biotech, and medical-device customers. Directly comparable as a vendor of gas-/vapor-phase decontamination systems targeting the same regulated end markets Sealive serves with steriXcure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Sealive compliance and trust

Trust signal

Compliance5 records

Sealive financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sealive leadership team

Management profile

Number of profiles

Profiles2 records

Sealive funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sealive M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sealive

What does Sealive do?

Sealive designs, manufactures and sells gas-phase nucleic-acid decontamination systems (steriXcure GE100S and steriXmini) powered by its proprietary Biovector® complex gas, which decomposes DNA and RNA structures to deliver SAL = Log10⁻⁶ sterility and 99.994% / LRV4.20 reduction of SARS-CoV-2 in laboratory, pharmaceutical, clean-room and animal-facility environments. Alongside this Life Science line, the company delivers contracted space-grade hardware, firmware and PCB design services — including DC-DC converters, SpaceWire FPGA logic and 5 kV DC MCP high-voltage power supplies — for JAXA/ISAS scientific-satellite programs such as SPRINT-A/EXCEED, GCOM-C and ASTRO-H/NeXT.

Is Sealive a public or private company?

Sealive is a private company. It is classified as corporate owned and is currently acquired.

When was Sealive founded?

Sealive was founded in 1995. It employs 11 to 50 people.

Where is Sealive based?

Sealive is headquartered in Niihama, Japan, in the Asia region.

How does Sealive make money?

Four revenue lines are on record. steriXcure / steriXmini equipment sales are the primary driver. The others are decontamination installation / nucleic-acid decontamination services, system Engineering contract design & development and HACCP management system marketing support (AWS-based).

Who are Sealive's main competitors?

Broad incumbents on record are Getinge, NEC (NEC Space Technologies), Advanced Sterilization Products (Johnson & Johnson MedTech) and Mitsubishi Electric. Noxilizer is listed as an emerging player. Direct peers are Bioquell (Ecolab), TOMI Environmental Solutions and STERIS.

Does Sealive have an API?

No public API is recorded for Sealive.

What industry is Sealive in?

Sealive's product category is Gas-Phase Sterilization and Decontamination Equipment. Its primary akta.pro industry code is HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA), with a secondary code of HLAGABAF, mRNA/LNP & Nucleic Acid Therapeutics CDMO. Its NAICS code is 333413 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales